Hair Removal Devices Market Top Players are Cynosure, Inc., Lumenis, and Alma Lasers

Hair Removal Devices Industry Overview

The global hair removal devices market size was valued at USD 1,083.83 million in 2021 and is anticipated to expand at a compound annual growth rate (CAGR) of 8.6% during the forecast period. There was a fall in the global market in 2020 due to the COVID-19 pandemic. The rise in beauty consciousness and growth in awareness about enhancing esthetic appeal are among the factors boosting the market. The COVID-19 pandemic had adversely impacted the beauty industry. The lockdown and restrictions have changed the purchase and usage behavior across the beauty and personal care space, which has resulted in a decrease in sales across many beauty segments.

However, the market is still recovering as some restrictions have been lifted and the spread of the virus is also declining. The growing awareness among people pertaining to their physical grooming and esthetics has led to high product demand. In the current scenario, people are highly concerned about their physical appearance. With the rise in disposable income levels, spending on personal care products is also increasing. This has boosted product sales. In addition, with the introduction of advanced products, the preference for noninvasive techniques for personal grooming is increasing. Potential risks associated with invasive procedures for improving esthetic appeal have led to the high demand for non-invasive or non-surgical techniques.

Gather more insights about the market drivers, restraints, and growth of the Global Hair Removal Devices market

There has been an increase in the availability of technologically advanced products. For instance, there have been consistent improvements in laser techniques, which have increased their efficiency and cost-effectiveness. Thus, benefits associated with the use of technologically advanced products are motivating people to use these tools. However, the high costs of laser products are expected to be an obstacle for people in developing regions. For instance, hair removal treatment on legs costs around USD 800 for a single session. This factor impacts their purchasing power, thereby leading to sluggish growth in developing regions.

Browse through Grand View Research's Medical Devices Industry Research Reports.

Laser Hair Removal Market - The global laser hair removal market size was valued at USD 798.6 million in 2021 and is expected to expand at a compound annual growth rate (CAGR) of 18.4% from 2022 to 2030.

Skincare Devices Market - The global skincare devices market size was valued at USD 12.5 billion in 2021 and is anticipated to witness a compound annual growth rate (CAGR) of 11.9% from 2022 to 2030.

Hair Removal Devices Market Segmentation

Grand View Research has segmented the global hair removal devices market on the basis of product, application, end-use, distribution channel, region:

Hair Removal Devices Product Outlook (Revenue, USD Million, 2017 - 2030)

• Laser Devices
• Intense Pulse Light Devices
• Other Energy-based Devices

Hair Removal Devices Application Outlook (Revenue, USD Million, 2017 - 2030)  

• Facial Hair Removal
• Legs
• Hands
• Others

Hair Removal Devices End-use Outlook (Revenue, USD Million, 2017 - 2030)  

• Beauty Clinics
• Dermatology Clinics
• Home Use

Hair Removal Devices Distribution Channel Outlook (Revenue, USD Million, 2017 - 2030)  

• Supermarkets and hypermarkets
• Drug-stores
• Online

Hair Removal Devices Regional Outlook (Revenue, USD Million, 2017 - 2030)

• North America
• Europe
• Asia Pacific
• Latin America
• MEA

Market Share Insights

Some of the major players in the global hair removal devices market are:

• Solta Medical, Inc.
• Cynosure, Inc.
• Lumenis
• Venus Concept Canada Corp.
• Alma Lasers
• Lutronic
• Cutera
• Syneron Medical Ltd.
• Sciton, Inc.
• Viora
• Panasonic Corporation
• Home Skinovations Ltd
• Procter & Gamble Company
• iluminage Beauty Inc.
• Koninklijke Philips N.V
• Dermacell Private Limited
• LASERBIO OPTOTECH LLP

Order a free sample PDF of the Hair Removal Devices Market Intelligence Study, published by Grand View Research.

Clinical Trial Imaging Market Application Outlook and Research Report by 2030

Clinical Trial Imaging Industry Overview

The global clinical trial imaging market size was estimated at USD 851.8 million in 2021and is expected to expand at a compound annual growth rate (CAGR) of 8.7% from 2022 to 2030. Mounting biotechnology and pharmaceutical industries combined with increased research and development investments for developing new drugs to treat diseases is expected to drive the market industry growth. Medical imaging plays an active role in the clinical development of novel life science products. Although the medical imaging industry is in a constant state of fluctuation, the biotechnology, and pharmaceutical industries continue to increase. This can be attributed to the enhanced investment in medical imaging companies and mergers and acquisitions, supported by the adoption of innovative imaging technologies to support clinical trials for medical devices.

However, the high cost of machinery and their installations, and the enormous cost of clinical trials may limit the market growth during the forecast period. Advancements in technology are bringing substantial improvements to the collection, evaluation, and submit clinical trial imaging data. Technology-enabled imaging, especially image analysis software, provides various benefits to clinical studies such as consistency, data accuracy, adaptability as well as compliance. For instance, image analysis software is used to direct and manage a reader via analysis of imaging time points.

Gather more insights about the market drivers, restraints, and growth of the Global Clinical Trial Imaging market

The outbreak of COVID-19 has adversely impacted the healthcare system in most countries, leading to a disruption in medical studies, research activities, and reduced sponsorship for research involving clinical trials. The pandemic has hampered the clinical trial timeline as numerous ongoing studies were delayed and planned studies were canceled. Unfavorable changes in regulations and guidelines, supply chain disruption, recruitment challenges for clinical trials, fear of viral spread, and shutting down of most manufacturers during lockdown have also adversely impacted the market. However, the introduction of virtual imaging trials during the COVID-19 pandemic is expected to open new avenues for the adoption of these devices. The development of advanced computational models helps has helped in better assessment of CT and radiography images which are expected to help in the early diagnosis of COVID-19 in patients. The clinical trial imaging market is said to bounce back by 2022 Q2, supported by the rise in R&D activities and improvement in supply and distribution channels.

Increased use of imaging technology along with the enhanced power of computing is expected to drive the usage of imaging in clinical trials. The Quantitative Imaging Biomarkers Alliance (QIBA) protocol has come up with standardized methods and imaging procedures with uniform procedures to be implemented for attaining statistical and precise endpoints in clinical trials.

For improving image assessment and capturing, numerous technology patents have been filed. Also, patented technologies are being provided by the imaging core lab players that are expected to aid the pharmaceutical companies in minimizing development timelines. For instance, a reading tool named Assessa, by IXICO aids in improved decision-making in clinical trials for diseases associated with memories such as schizophrenia, Parkinson’s, and Alzheimer’s disease, and neurological disorders like dementia and cognitive impairment.

Browse through Grand View Research's Medical Devices Industry Research Reports.

Medical X-ray Generators Market - The global medical X-ray generators market size was valued at USD 2.01 billion in 2022 and is expected to expand at a compound annual growth rate (CAGR) of 5.1% from 2023 to 2030.

Digital X-ray Devices Market - The global digital X-ray devices market size was valued at USD 3.6 billion in 2022 and is expected to expand at a compound annual growth rate (CAGR) of 3.0% from 2023 to 2030.

Clinical Trial Imaging Market Segmentation

Grand View Research has segmented the global clinical trial imaging market based on service, application, end-use, and region:

Clinical Trial Imaging Service Outlook (Revenue, USD Million, 2018 - 2030)

• Clinical Trial Design and Consultation Services
• Reading and Analytical Services
• Operational Imaging Services
• System and Technology Support Services
• Project and Data Management

Clinical Trial Imaging Application Outlook (Revenue, USD Million, 2018 - 2030)

• NASH
• CKD
• Diabetes
• Cardiovascular Diseases
• Musculoskeletal
• Oncology
• Gastroenterology
• Pediatrics
• Others

Clinical Trial Imaging End-use Outlook (Revenue, USD Million, 2018 - 2030)

• Biotechnology and Pharmaceutical companies
• Medical Devices Manufacturers
• Academic and Government Research Institutes
• Contract Research Organizations (CROs)
• Others

Clinical Trial Imaging Regional Outlook (Revenue, USD Million, 2018 - 2030)

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa

Market Share Insights

February 2020: ICON plc acquired MedPass International, a European medical devices CRO, reimbursement, and regulatory consultancy. This acquisition has reportedly helped in the expansion of the medical device and diagnostic research services of ICON in Europe.

June 2018: Bioclinica introduced the SMART technology suite available with Medical Imaging, Interactive Response Technology (IRT), and Electronic Data Capture (EDC) to submit, manage, investigate, report & transfer medical image data compliant with universal data privacy and global requirements.

Key Companies profiled:

Some of the prominent players in the global clinical trial imaging market include:

• IXICO plc
• Navitas Life Sciences
• Resonance Health
• ProScan Imaging
• Radiant Sage LLC
• Medpace
• Biomedical Systems Corp
• Cardiovascular Imaging Technologies
• Intrinsic Imaging
• BioTelemetry

Order a free sample PDF of the Clinical Trial Imaging Market Intelligence Study, published by Grand View Research.

Sternal Closure Systems Market is driven by Rise in the Number of Cardiothoracic Surgical Procedure

Sternal Closure Systems Industry Overview

The global sternal closure systems market size was estimated to be valued at USD 2.39 billion in 2021 and is projected to expand at a compound annual growth rate (CAGR) of 5.4% from 2022 to 2030. The expanding base of the geriatric population undergoing open-heart surgery through median sternotomy is considered to be one of the primary growth stimulants for the market. The median sternotomy procedure has remained the most popular technique for cardiac exposure to date, owing to easy and quick access to heart valves and vessels.

Sternotomy and sternal closure occur prior to and post-cardiac surgery respectively. Moreover, rapid technological advancements, such as the use of biocompatible polymers including PEEK, tritium, nitinol, pre-sternotomy plates, and the development of minimal invasive median sternotomy procedures, are expected to drive the market growth.

Gather more insights about the market drivers, restraints, and growth of the Global Sternal Closure Systems market

A rise in the number of surgical procedures globally has driven demand for surgical instruments leading to the growth of the market. According to OECD, the estimated surgical procedures in 2012 were around 399,952 in the U.K., which later increased to 491,604 by 2016. Furthermore, lack of exercise and poor nutrition increase the risk of heart diseases in the elderly population. Furthermore, the growing geriatric population, which is more susceptible to chronic CVDs, is leading to an increase in the number of cardiovascular surgical procedures, thereby boosting the demand for sternal closure systems globally.

Moreover, developing countries are focusing on investing in public healthcare infrastructure due to the rise in non-communicable disease burden and injuries, which will further increase the number of surgical procedures in developing regions as well. According to data published by the world bank, in 2015, China's per capita healthcare expenditure was USD 425.6 accounting for 5.3% of GDP. Furthermore, the Plan of Health China 2030 estimates that by 2020 healthcare spending is expected to account for 6.5% to 7% of its total GDP.

Sedentary lifestyles, high smoking & alcohol consumption, and unhealthy diet are leading to an increase in the prevalence of cardiac diseases globally. This is resulting in a rise in surgical procedures, which in turn, is likely to fuel the adoption of sternal closure systems in surgeries over the coming years. According to a survey conducted by the Centers for Disease Control and Prevention, in 2016, 28.1 million adults in the U.S. were diagnosed with heart disease.

Browse through Grand View Research's Medical Devices Industry Research Reports.

Heart Closure Devices Market - The global heart closure devices market size was valued at USD 2.36 billion in 2022 and is expected to grow at a compound annual growth rate (CAGR) of 14.9% from 2023 to 2030.

Electrophysiology Devices Market - The global electrophysiology devices market size was valued at USD 6.1 billion in 2022 and is expected to expand at a compound annual growth rate (CAGR) of 11.16% from 2023 to 2030.

Sternal Closure Systems Market Segmentation

Grand View Research has segmented the global sternal closure systems market based on product, procedure, material and region:

Sternal Closure Systems Product Outlook (Revenue, USD Million, 2018 - 2030)

• Closure Devices
• Bone Cement

Sternal Closure Systems Procedure Outlook (Revenue, USD Million, 2018 - 2030)

• Median Sternotomy
• Hemisternotomy
• Bilateral Thoracosternotomy
• Others

Sternal Closure Systems Material Outlook (Revenue, USD Million, 2018 - 2030)

• Titanium
• Polyether Ether Ketone (PEEK)
• Stainless Steel
• Others

Sternal Closure Systems Regional Outlook (Revenue, USD Million, 2018 - 2030)

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa

Market Share Insights

December 2020: Zimmer Biomet Holdings Inc., acquired A&E Medical Corporation to gain access to its sternal closure device portfolio, ensuring long-term growth.

September 2019: DePuy Synthes launched the CONDUIT interbody Platform with EIT cellular titanium technology to expand its product portfolio of degenerative spine diseases.

Key Companies profiled:

Some prominent players in the global sternal closure systems market include:

• Zimmer Biomet
• Johnson & Johnson
• Braun Melsungen AG
• Orthofix Holdings, Inc.
• GE Healthcare
• KLS Martin Group
• A&E Medical Corporation
• Jace Medical, LLC
• Acute Innovations
• Abyrx, Inc.
• Kinamed Incorporated      

Order a free sample PDF of the Sternal Closure Systems Market Intelligence Study, published by Grand View Research.

Biopharmaceuticals Contract Manufacturing Market Restraint Analysis Report by 2030

Biopharmaceuticals Contract Manufacturing Industry Overview

The global biopharmaceuticals contract manufacturing market was valued at USD 17.0 billion in 2021 and is projected to grow at a compound annual growth rate (CAGR) of 5.2% during the forecast period. The success of the biopharmaceutical market can be majorly attributed to the contract manufacturers. Reduction in the overall investment required to bring a new drug product to market, providing access to expensive technologies, quick entry of products into the markets, and greater flexibility are some advantages offered by contract manufacturing organizations (CMOs), which have prompted the companies to outsource their biopharmaceutical manufacturing.

Due to the disruptions from COVID-19, many companies have had to bring on new contract manufacturers or ingredient suppliers due to increasing demands. Furthermore, with a perpetual expansion of the biopharmaceutical industry, the companies are facing production issues, such as lack of expertise and sophisticated equipment, while practicing in-house manufacturing. The maturity of biotechnology and the availability of external funding have resulted in the growth in a number of early-stage bio/pharma companies. These companies are recognized as core customers of CMOs, as these organizations lack the capabilities for the development of robust manufacturing operations.

Gather more insights about the market drivers, restraints, and growth of the Global Biopharmaceuticals Contract Manufacturing market

In order to fulfill the growing demand in the market, key players are going for capacity expansion. For instance, in 2020, Thermo Fisher Scientific announced an investment of USD 180.0 million for the construction of a new commercial manufacturing site in Plainville, Mass for viral vector development and manufacturing services. Also, in 2019, Boehringer Ingelheim invested USD 84 million for expansion in Mexico for increasing production. The customers and CMOs are engaged in standardizing agreement terms for making contract negotiations easy. This is to address the issues pertaining to the regulatory landscape and complexity of service delivery. IP rights, warranty & liabilities, prices & timelines are major issues cited by CMOs and clients which are making negotiations innately difficult.

Breakthrough technological advancements and innovations in bioprocessing have played a pivotal role in the progress of contract service providers by overcoming the manufacturing issues such as high production costs and the need for changeover with every batch. Single-use bioprocessing systems are one of the most significant innovations as it helps in reducing the overall production and scale-up costs. Furthermore, the fast turnaround offered by single-use products while limiting allied activities, such as changeover and cleaning validation, has supported the growth of CMOs to a major extent.

Mergers, acquisitions, and joint ventures are one of the common trends observed across the industry, as it helps CMOs offer integrated bioprocessing services to their clients, which, in turn, makes them a more reliable option for a rapid product launch for commercial use. However, large firms consider outsourcing perilous due to loss of strategic control and limited management oversight. As a result, large pharma companies opt to maintain their manufacturing operations in-house. This is expected to challenge the growth of CMOs to a certain extent.

Browse through Grand View Research's Medical Devices Industry Research Reports.

Nutraceutical Contract Manufacturing Services Market - The nutraceutical contract manufacturing services market size was estimated at USD 133.34 billion in 2022 and is expected to expand at a compound annual growth rate (CAGR) of 12.04% from 2023 to 2030.

Generic Pharmaceuticals Contract Manufacturing Market - The global generic pharmaceuticals contract manufacturing market size was valued at USD 63.7 billion in 2021 and is expected to grow at a compound annual growth rate (CAGR) of 5.8% from 2022 to 2030.

Biopharmaceuticals Contract Manufacturing Market Segmentation

Grand View Research has segmented the global biopharmaceuticals contract manufacturing market based on source, service, product, therapeutic area and region: 

Biopharmaceuticals Contract Manufacturing Source Outlook (Revenue, USD Million, 2017 - 2030)

• Mammalian
• Non-mammalian

Biopharmaceuticals Contract Manufacturing Service Outlook (Revenue, USD Million, 2017 - 2030)

• Process Development
• Fill & Finish Operations
• Analytical & QC studies
• Packaging

Biopharmaceuticals Contract Manufacturing Product Outlook (Revenue, USD Million, 2017 - 2030)

• Biologics
• Biosimilars

Biopharmaceuticals Contract Manufacturing Therapeutic Area Outlook (Revenue, USD Million, 2017 - 2030)

• Oncology
• Autoimmune Diseases
• Metabolic Diseases
• Cardiovascular Diseases
• Neurology
• Infectious Diseases
• Others

Biopharmaceuticals Contract Manufacturing Regional Outlook (Revenue, USD Million, 2017 - 2030)

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa

Key Companies profiled:

Some prominent key players in the global biopharmaceuticals contract manufacturing market include:

• Boehringer Ingelheim GmbH
• Lonza
• Inno Biologics Sdn Bhd
• Rentschler Biotechnologie GmbH
• JRS PHARMA
• AGC Biologics
• ProBioGen
• FUJIFILM Diosynth Biotechnologies U.S.A., Inc.
• Toyobo Co. Ltd.
• Samsung BioLogics
• Thermo Fisher Scientific, Inc.
• Binex Co., Ltd.
• WuXi Biologics
• AbbVie, Inc.
• Novartis AG
• ADMA Biologics, Inc.
• Catalent, Inc
• Cambrex Corporation
• Pfizer Inc.
• Siegfried Holding AG

Order a free sample PDF of the Biopharmaceuticals Contract Manufacturing Market Intelligence Study, published by Grand View Research.

Colposcopy Market Business Drivers, Top Companies and Competitive Analysis

Colposcopy Industry Overview

The global colposcopy market size was valued at USD 427.0 million in 2021 and is anticipated to expand at a compound annual growth rate (CAGR) of 4.8% from 2022 to 2030. Factors such as the rise in the prevalence of cervical cancer and the high demand for early diagnostic techniques are expected to boost market growth. According to Global Cancer Observatory, in 2020, about 604,127 new cases of cervical cancer were diagnosed globally and 341,831 deaths occurred in the same year due to the disease. Additionally, by 2025, the incidence of cervical cancer is expected to increase to 1,495,211.

Colposcopy is a highly efficient technique for early diagnosis of lesions and selecting biopsy sites due to its high precision, adaptability, ease of use, and non-invasive approach. It further allows for a magnified evaluation of the cervix and lower genital tract for either dysplastic or malignant epithelial lesions. For decades, gynecological examinations were subjected to a time-consuming and inconvenient clinical experience including outmoded equipment and an uncomfortable visit. However, in recent years, there have been significant technological advancements in this field. Major market players have been adopting advanced technologies by integrating various digital platforms with colposcopy equipment. 

Gather more insights about the market drivers, restraints, and growth of the Global Colposcopy market

The integration is expected to introduce high-resolution imaging devices that are most likely to replace traditional colposcopes, hence influencing the market dynamics. Increasing awareness and adoption of preventive healthcare and disease screening programs is expected to propel the growth of the market. For instance, in April 2021, as part of China's efforts to protect women's health, more than 120 million cervical cancer screenings were conducted for free. Improved image quality is expected to improve diagnostic precision in the early stages of cervical cancer. This can help with a faster diagnosis and treatment. Thus, the growing usage of colposcopy for diagnosing various diseases is expected to contribute to market growth. 

The COVID-19 pandemic negatively impacted the market for colposcopy. A significant decline in cancer screening was witnessed across the globe. However, the market is expected to steadily grow by mid-2022. The WHO also aims at reducing 10% cases of cervical cancer by 2030, and preventing 70 million cases by 2120, by encouraging end-users to adopt high-end technologies for early detection of the disease. This is expected to significantly boost the market in the coming years. 

Browse through Grand View Research's Medical Devices Industry Research Reports.

Gynecological Devices Market - The global gynecological devices market size was valued at USD 8.54 billion in 2021 and is anticipated to grow at a compound annual growth rate (CAGR) of 8.62% over the forecast period.

Portable Ultrasound Devices Market - The global portable ultrasound devices market size was valued at USD 1.70 billion in 2021 and is expected to expand at a compound annual growth rate (CAGR) of 5.6% from 2022 to 2030.

Colposcopy Market Segmentation 

Grand View Research has segmented the global colposcopy market based on modality, application, portability, end-use, and region:

Colposcopy Modality Outlook (Revenue, USD Million, 2018 - 2030)

• Optical
• Video

Colposcopy Application Outlook (Revenue, USD Million, 2018 - 2030)

• Pelvic
• Oral

Colposcopy Portability Outlook (Revenue, USD Million, 2018 - 2030)

• Handheld
• Stationary

Colposcopy End-use Outlook (Revenue, USD Million, 2018 - 2030)

• Hospitals
• Diagnostic centres
• Gynaecology clinic
• Specialty clinics
• Ambulatory surgical centre
• Research and academics

Colposcopy Regional Outlook (Revenue, USD Million, 2018 - 2030)

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East and Africa

Market Share Insights

July 2021: DYSIS Medical Inc. announced the launch of DYSIS View - a compact and portable colposcope that uses the company's cutting-edge computer-aided cervical mapping technology, aiding healthcare professionals in clearly detecting cervical abnormalities.

Key Companies profiled:

Some of the prominent players in the colposcopy market include:

• Kaps GmbH & Co. KG
• Carl Zeiss Meditec AG
• CooperSurgical, Inc
• DYSIS Medical Inc
• ATMOS Medizin Technik GmbH & Co. KG
• Olympus Corporation
• McKesson Medical-Surgical Inc.
• Ecleris
• Optomic
• Seiler Instrument Inc. 

Order a free sample PDF of the Colposcopy Market Intelligence Study, published by Grand View Research.

X-ray Systems Market is driven by Increasing Number of Government Initiatives, 2030

X-ray Systems Industry Overview

The global x-ray systems market size was valued at USD 6.7 billion in 2021 and is anticipated to expand at a compound annual growth rate (CAGR) of 2.3% from 2022 to 2030. Major factor driving the market is increase in the demand for early-stage diagnosis of chronic diseases. In addition, continuous technological advancements, rise in product development, improved fundings, and investments by the government, especially in developing countries, such as India and China, are also expected to contribute to the market growth. For instance, in June 2021 the government of India launched X-Ray Setu, a free Artificial Intelligence (AI) based platform to aid doctors for early Covid interventions.

Over the last few years, medical imaging has undergone a drastic evolution owing to digital radiology solutions. Diagnostic accuracy is at the core of the healthcare industry, and digital X-ray imaging plays a significant role in improving diagnostic accuracy. In addition, the integration of AI in these systems has contributed to market growth. For instance, in August 2021, GE Healthcare announced a partnership with Amazon Web Services (AWS) to provide AI and cloud-based imaging solutions to hospitals and healthcare providers. Furthermore, major market players are engaged in the development of advanced modalities such as multimodal/hybrid imaging systems.

Gather more insights about the market drivers, restraints, and growth of the Global X-ray Systems market

For instance, in October 2021, Siemens Healthineers launched Luminos Impulse, a 2-in-1 remote-controlled imaging device that integrates fluoroscopy and radiography for improved clinical productivity and efficiency. Increasing awareness and adoption of preventive healthcare and disease screening programs is expected to propel market growth. Improvement in the quality of image output is expected to enhance diagnostic accuracy in the early stages of various diseases. This can help with the faster diagnosis and treatment of a variety of life-threatening disorders, including cancer and a number of cardiovascular conditions. Thus, the growing usage of x-ray systems for diagnosing various diseases is expected to contribute to market growth.

The COVID-19 pandemic has posed challenges and changed healthcare systems globally. Radiology has considerably improved patient care in this crisis, owing to rapid advancements.The first imaging procedure that played an important role in the treatment of COVID-19 was chest radiography, since it plays a major role in the diagnosis of COVID-19. Furthermore, the demand for mobile x-ray systems has increased as a result of the COVID-19 pandemic. With the consumers being more aware of the benefits of mobile x-ray systems and the possibility of another pandemic in the future, healthcare facilities may consider switching to mobile diagnostic equipment owing to its faster image processing, workflow optimization, integrated AI, and other features.

Browse through Grand View Research's Medical Devices Industry Research Reports.

Medical X-ray Generators Market - The global medical X-ray generators market size was valued at USD 2.01 billion in 2022 and is expected to expand at a compound annual growth rate (CAGR) of 5.1% from 2023 to 2030.

Teleradiology Market - The global teleradiology market size was valued at USD 2.17 billion in 2021 and is anticipated to expand at a CAGR of 12.5% from 2022 to 2030.

X-ray Systems Market Segmentation

Grand View Research has segmented the global x-ray systems market report on the basis of modality, technology, mobility, end use, region:

X-ray Systems Modality Outlook (Revenue, USD Million, 2017 - 2030)

• Radiography
• Fluoroscopy
• Mammography

X-ray Systems Technology Outlook (Revenue, USD Million, 2017 - 2030)

• Digital radiography
• Computed radiography

X-ray Systems Mobility Outlook (Revenue, USD Million, 2017 - 2030)

• Stationary
• Mobile

X-ray Systems End-use Outlook (Revenue, USD Million, 2017 - 2030)

• Hospitals
• Diagnostic imaging centres

X-ray Systems Regional Outlook (Revenue, USD Million, 2017 - 2030)

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East and Africa

Market Share Insights

November 2021: GE Healthcare received FDA clearance for its artificial intelligence (AI) algorithm to help healthcare professionals evaluate Endotracheal Tube (ETT) placements.

March 2021: Siemens Healthineers introduced Mammovista B.smart, software that speeds up the reading process for breast imaging.

March 2021: Fujifilm Ltd., a leader in imaging and healthcare technologies, announced the launch of t FDR micro, a mobile digital radiology system, which provides high-resolution imaging with low X-ray doses.

Key Companies profiled:

Some of the prominent players in the X-ray systems market include:

• Koninklijke Philips N.V. 
• Siemens Healthineers AG
• GE Healthcare
• Canon Medical Systems
• Shimadzu Corporation
• FUJIFILM SonoSite, Inc.
• Carestream
• Mindray Medical International Limited
• Hologic, Inc
• New Medical Imaging
• AGFA

Order a free sample PDF of the X-ray Systems Market Intelligence Study, published by Grand View Research.

Huntington's Disease Treatment Market List of Key Distributors and Channel Partners, 2030

Huntington's Disease Treatment Industry Overview

The global huntington’s disease treatment market size was valued at USD 362.0 million in 2021 and is expected to expand a compound annual growth rate (CAGR) of 19.6% from 2022 to 2030. The expected label expansion of Ingrezza for treating chorea associated with Huntington’s disease, high burden of HD in western countries, and strong product pipeline of disease-modifying therapies are anticipated to be major drivers for the market.HD roughly affects 30,000 people in North America, with a prevalence of 5.7 per 100,000 people. HD in children is considerably rarer, accounting for about 5% to 10% of all cases. It affects up to 10 out of 100,000 people in Europe.

Huntington's Disease (HD) is a progressive neurological condition caused by CAG expansions in the Huntingtin (Htt) gene. It affects one out of every 10,000 people in the United States. Healthy people have less than 35 CAG repetitions, whereas HD patients have CAG expansions ranging from 36 to 200. The prevalence varies by more than ten-fold between geographical locations, which can be related to variations in case ascertainment and diagnostic criteria. The Asian population has consistently had a lower prevalence, while Europe, North America, and Australia have a higher prevalence. Several small molecules in clinical development are focused on using immunomodulatory drugs to target the overactive immune system in HD.

Gather more insights about the market drivers, restraints, and growth of the Global Huntington's Disease Treatment market

Annexon, Inc. is engaged in the development of ANX005-an experimental monoclonal antibody that targets abnormal C1q activity in complement-mediated neurodegenerative diseases, such as HD. This innovative medication is administered intravenously (IV) and is meant to suppress C1q and the complete classical complement system. In November 2020, the company initiated a phase 2 clinical trial of ANX005 for treating HD patients. Stem cell therapy is also generating interest as a potential treatment for HD. Currently, Cellavita, in collaboration with AzidusPharma, is investigating stem cell therapy, CELLAVITA-HD in phase 2/ 3 ADORE-DH trial.

However, drug development for HD has faced significant obstacles as several therapies have failed to demonstrate efficacy or were associated with significant toxicity. In March 2021, F. Hoffmann-La Roche Ltd. discontinued the dosing in the phase III GENERATION HD1 study of tominersen in manifest HD. The conclusion was made on the basis of findings of an unblinded Independent Data Monitoring Committee's (iDMC) preplanned examination of data from the phase III research. During analysis of this data, no new or developing safety signals for tominersen were discovered.COVID-19 pandemic has had a slight negative impact on the market for Huntington’s disease treatment. However, the delays in conducting clinical trials due to the pandemic can delay the entry of pipeline candidates into the market.

Browse through Grand View Research's Pharmaceuticals Industry Research Reports.

Parkinson’s Disease Treatment Market - The global Parkinson’s disease treatment market size was valued at USD 4.28 billion in 2021 and is expected to expand at a compound annual growth rate (CAGR) of 12.1% from 2022 to 2030.

Inflammatory Bowel Disease Treatment Market - The global inflammatory bowel disease treatment market size was valued at USD 20.33 billion in 2022 and is expected to expand at a compound annual growth rate (CAGR) of 3.6% from 2023 to 2030.

Huntington’s Disease Treatment Market Segmentation

Grand View Research has segmented the global Huntington’s disease treatment market on the basis of treatment and region:

Huntington’s Disease Treatment Outlook (Revenue, USD Million, 2017 - 2030)

• Symptomatic Treatment
• Disease Modifying Therapies

Huntington’s Disease Treatment Regional Outlook (Revenue, USD Million, 2017 - 2030)

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa

Market Share Insights

September 2021: NeuExcell Therapeutics Inc entered into a partnership with Spark Therapeutics, Inc. (F. Hoffmann La Roche Ltd. owned subsidiary) for the development of gene therapy for treating HD patients. Under the terms of the agreement, NeuExcell Therapeutics is entitled to receive upfront license fees, R&D, and sales milestone payments of up to approximately USD 190 million and additional product royalties.

September 2021: Prilenia Therapeutics B.V. announced its participation in H.C. Wainwright 23rd Annual Global Investment Conference, Cantor Virtual Global Healthcare Conference, and European Huntington's Disease Network for showcasing the topline results of phase 3 candidatepridopidine. These healthcare conferences are an excellent platform for increasing the customer base.

Key Companies profiled:

Some of the prominent players in the Huntington’s disease treatment market include:

• Lundbeck A/S
• Teva Pharmaceutical Industries Ltd.
• Bausch Health Companies Inc.
• Hetero
• Lupin
• Hikma Pharmaceuticals PLC
• Reddy’s Laboratories Ltd.
• Sun Pharmaceutical Industries Ltd.

Order a free sample PDF of the Huntington's Disease Treatment Market Intelligence Study, published by Grand View Research.

Endoscopes Market Size Is Expected to Reach USD 27.9 billion by 2030

Endoscopes Industry Overview

The global endoscopes market size was valued at USD 13.6 billion in 2022 and is expected to expand at a compound annual growth rate (CAGR) of 9.4% from 2023 to 2030. The rise in prevalence of chronic disorders and the growing awareness of early detection of diseases through minimally invasive surgical procedures are some of the major factors anticipated to drive the market growth over the forecast years. In addition, favorable reimbursement policies, and increasing FDA approvals for endoscopic devices are also expected to boost the growth of the market over the years. For instance, in 2021, the United States Food and Drug Administration granted 510(k) clearance to EndoFresh’s disposable digestive endoscopy system, a device developed to reduce the chance of contamination in gastrointestinal procedures.

Furthermore, endoscopic procedures have been largely adopted to diagnose and treat functional gastrointestinal disorders. Functional gastrointestinal disorders can affect any part of the gastrointestinal tract, including the stomach, esophagus, and intestines. The growing prevalence of functional gastrointestinal disorders, such as Irritable Bowel Syndrome (IBS), functional constipation, or functional dyspepsia, is also expected to accelerate the adoption of endoscopy devices and boost the market growth over the forecast years. For instance, in 2021, a multinational study published in the Gastroenterology journal on 33 countries reported that, globally, over 40% of persons have functional gastrointestinal disorders.

Gather more insights about the market drivers, restraints, and growth of the Global Endoscopes market

In addition, obesity is a growing serious health problem globally due to unhealthy lifestyles and diets. It is associated with several gastrointestinal disorders, such as esophageal adenocarcinoma, erosive esophagitis, gastroesophageal reflux disease, colorectal polyps, and cancer. As per the Organization for Economic Co-operation and Development (OECD) data, the obesity rate is expected to grow at a significant rate by 2030. Nearly 47%, 39%, and 35% of the population in the U.S., Mexico, and England respectively are expected to be obese by 2030. Bariatric surgery is the most effective treatment option resulting in significant weight loss. However, the emergence of minimally invasive endoscopic sleeve gastroplasty procedures significantly reduces stomach volume.

It is performed through patients’ mouths unlike traditional bariatric surgery using a flexible endoscope. Hence, the increase in demand for minimally invasive endoscopic bariatric procedures is further anticipated to drive market growth over the years. Furthermore, the growing global burden of cancer all over the world is also driving the demand for endoscopes for early diagnosis and treatment. For instance, according to Globocan 2020 report, the estimated number of new cancer cases was 19.3 million in 2020 and the number of deaths that occurred due to cancer was about 10 million. Thus, increasing demand for endoscopic biopsy to diagnose cancer is anticipated to drive the market growth during the forecast years.

A decrease in the number of endoscopic procedures during the COVID-19 pandemic hampered the market growth in 2020. Due to the risk of cross-contamination and the chance of SARS-CoV-2 transmission, several endoscopic facilities have canceled or postponed the elective, and semi-urgent procedures, which is restraining the market growth during this period. Furthermore, supply chain disruption and changing regulations to curtail the infection are also some of the major factors that hindered the growth of the market in 2020. For instance, a study on the endoscopy unit of the Cancer Institute of the State of São Paulo (ICESP), published in Clinics (Sao Paulo) journal in 2021, stated that there is a 55% reduction in the endoscopic procedure during the pandemic and the colonoscopy is the most affected modality (-79%).

Browse through Grand View Research's Medical Devices Industry Research Reports.

Rigid Endoscopes Market - The global rigid endoscopes market size was valued at USD 6.0 billion in 2022 and is projected to expand at a compound annual growth rate (CAGR) of 7.1% from 2023 to 2030.

Flexible Endoscopes Market - The global flexible endoscopes market size was valued at USD 8.96 billion in 2022 and is expected to expand at a compound annual growth rate (CAGR) of 7.6% from 2023 to 2030.

Endoscopes Market Segmentation

Grand View Research has segmented the global endoscopes market based on product, application, end use, and region:

Endoscopes Product Outlook (Revenue, USD Million, 2014 - 2030)

• Rigid Endoscopes
• Flexible Endoscopes
• Capsule Endoscopes
• Disposable Endoscopes
• Robot-assisted Endoscopes

Endoscopes Application Outlook (Revenue, USD Million, 2014 - 2030)

• Gastrointestinal (GI) Endoscopy
• Laparoscopy
• Obstetrics/Gynecology Endoscopy
• Arthroscopy
• Urology Endoscopy (Cystoscopy)
• Bronchoscopy
• Mediastinoscopy
• Otoscopy
• Laryngoscopy
• Other Applications

Endoscopes End-use Outlook (Revenue, USD Million, 2014 - 2030)

• Hospitals
• Ambulatory Surgery Centers/Clinics
• Other End Uses

Endoscopes Regional Outlook (Revenue, USD Million, 2014 - 2030)

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East Africa

Market Share Insights

January 2021: Olympus Corp. acquired Quest Photonic Devices to strengthen its presence in the surgical endoscopy market.

Key Companies profiled:

Some prominent players in the global endoscopes market include:

• Olympus Corp.
• PENTAX Medical
• Ethicon US, LLC
• FUJIFILM Holdings Corp.
• Stryker
• Boston Scientific Corp.
• CONMED Corp.
• Karl Storz GmbH & Co., KG
• Richard Wolf Medical Instruments
• Medtronic

Order a free sample PDF of the Endoscopes Market Intelligence Study, published by Grand View Research.

U.S. Practice Management Systems Market Major Deals and Strategic Alliances Analysis Report by 2030

U.S. Practice Management Systems Industry Overview

The U.S. practice management systems market size was valued at USD 7.39 billion in 2021 and is expected to expand at a compound annual growth rate (CAGR) of 4.5% from 2022 to 2030. The rising need to achieve operational efficiency, enhanced documentation with minimal errors, and financial viability for physicians' practice are the key facilitators for the adoption of practice management systems. Moreover, rapid penetration of IT and a rising number of supportive federal initiatives in the U.S. to amalgamate health records on a single platform are further anticipated to provide lucrative growth opportunities to the market.

Increasing pressure to curb healthcare costs along with changing dynamics of hospital/healthcare settings is fueling the demand for practice management systems in the U.S. Factors such as the rising focus on implementing cost-effective and high-quality care are also likely to contribute toward the market development. Healthcare institutes are witnessing a paradigm shift in the U.S. as a result of the changing dynamics of the business models.

Gather more insights about the market drivers, restraints, and growth of the U.S. Practice Management Systems market

The HITEC act implemented for improved healthcare delivery and for providing quality services to patients is further contributing to the growth of the market for practice management systems in the U.S. Adoption of healthcare IT solutions witnessed a surge during the COVID-19 pandemic is expected to provide this market with lucrative growth opportunities.

The COVID-19 pandemic accelerated transformational changes in how healthcare is delivered to patients and accessed while addressing issues such as providing cost-effective and personalized care. Various companies have upgraded their practice management solutions to provide suitable patient-centric services. For instance, Benchmark Systems Inc. in the U.S. offers fully integrated solutions to automate healthcare workflows. This company is acquired by CloudMD Software & Services Inc. in September 2020.

The partnership agreements, collaborations, and mergers by the key players to provide cloud-based solutions to their customers are expected to drive market growth. According to the M&A database of Mercom, companies operational in practice management solutions had completed around 173 deals in the past decade. Philips and Allscripts are amongst the top acquirers.

The development of new value-added services like integration of practice management systems with other healthcare IT solutions, such as Computerized Physician Order Entry (CPOE) and laboratory information systems, is anticipated to propel the market demand in the U.S. over the next few years.

Increasing cases of obesity and other chronic diseases are also expected to boost the market over the forecast period. According to a report by the Center for Disease Prevention and Control (CDC), around one-third population in the U.S. is obese. The geriatric population prone to diabetes and cardiovascular diseases further increases the rate of hospitalization. Moreover, growing incidences of drug resistance further increase the demand to maintain the medical history of patients, which is expected to propel the growth of the U.S. practice management systems market.

Browse through Grand View Research's Healthcare IT Industry Research Reports.

Physical Therapy Software Market - The global physical therapy software market size was valued at USD 1.09 billion in 2021 and is expected to expand at a compound annual growth rate (CAGR) of 10.1% throughout the forecast period.

Internet of Things in Healthcare Market - The global internet of things in healthcare market size was valued at USD 252.1 billion in 2022 and is expected to expand at a compound annual growth rate (CAGR) of 16.8% from 2023 to 2030.

U.S. Practice Management Systems Market Segmentation

Grand View Research has segmented the U.S. practice management systems market based on product, component, delivery mode, and end use:

U.S. Practice Management Systems Product Outlook (Revenue, USD Million, 2017 - 2030)

• Integrated
• Standalone

U.S. Practice Management Systems Component Outlook (Revenue, USD Million, 2017 - 2030)

• Software
• Services

U.S. Practice Management Systems Delivery Mode Outlook (Revenue, USD Million, 2017 - 2030)

• On-premise
• Web-based
• Cloud-based

U.S. Practice Management Systems End-use Outlook (Revenue, USD Million, 2017 - 2030)

• Physician Back Office (Solo practitioners)
• Hospitals (Group practitioners)
• Pharmacies
• Diagnostic Laboratories
• Other Settings

Market Share Insights

July 2019: Henry Schein acquired Elite Computer Italia, which is a dental practice management software company, to improve its regional presence.

March 2019: McKesson Corporation collaborated with Navigating Cancer to improve the Patient Relationship Management (PRM) platform for community-based oncologists.

Key Companies profiled:

Some prominent players in the U.S. practice management systems market include:

• Henry Schein MicroMD
• Allscripts Healthcare Solutions, Inc.
• AdvantEdge Healthcare Solutions, Inc.
• Cerner Corporation
• GE Healthcare
• McKesson Corporation
• Athenahealth, Inc.
• EPIC Systems Corporation
• Accumedic Computer Systems, Inc.
• NextGen Healthcare Information System LLC
• eClinicalWorks LLC
• CareCloud
• Kareo
• AdvancedMD
• DrChrono, Inc
• CollaborateMD
• Office Ally

Order a free sample PDF of the U.S. Practice Management Systems Market Intelligence Study, published by Grand View Research.

Flat Panel Detector Based X-ray for Cone Beam Computed Tomography Market Share Analysis by 2030

Flat Panel Detector Based X-ray for Cone Beam Computed Tomography Industry Overview

The flat panel detector based x-ray for cone beam computed tomography market size was valued at USD 2.3 billion in 2021 and is expected to expand at a compound annual growth rate (CAGR) of 7.3% from 2022 to 2030. Increased adoption of low radiation X-ray imaging systems is one of the significant factors fueling the market growth. Cone beam computed tomography (CBCT) has become a standard of care in various dental applications owing to its advantages over the other radiographic imaging modalities. These advantages include limited exposure to radiation, improved image accuracy, reduced image artifacts, rapid scanning, and the ability to maintain data records.

Developments in technology have enabled the integration of CBCT and software for efficient diagnosis and treatment of various dental indications. CBCT has increased the success rate of microsurgical and nonsurgical endodontic treatments owing to its high-quality three-dimensional imaging. Furthermore, most CBCT systems incorporate panoramic and cephalometric modalities in addition to 3D imaging. Many professionals find it convenient to use the 2D CBCT-generated reconstruction of cephalometric images.

Gather more insights about the market drivers, restraints, and growth of the Global Flat Panel Detector Based X-ray for Cone Beam Computed Tomography market

The market is moderately competitive due to few players capturing a larger market share and a limited number of products. VATECH and Asahi Roentgen are the companies that manufacture the highest variants of CBCT devices. The innovators and early adopters in this market have their bases in Japan, Korea, Finland, the U.S., France, and Italy. However, the adoption of CBCT technology is high in North America and European countries.

The American Academy of Oral and Maxillofacial Radiology, the American Association of Endodontists, and the American Dental Association Council on Scientific Affairs have developed guidelines specifically related to the use of CBCT in medical and dental practice in the U.S. The European Academy of Dental and Maxillofacial Radiology has created a set of evidence-based guidelines for the use of CBCT for dental and maxillofacial applications. The awareness related to the use of CBCT is very less in most countries. However, the inclusion of CBCT in academics significantly contributes to the rapidly increasing awareness among the students and practitioners.

The Covid 19 pandemic led to a dramatic decline since its outbreak in the year 2020. Postponing of elective surgeries, halt in logistics and sales, national lockdowns, the closure of manufacturing units, and financial instability among end-users led to the reduced demand for these systems in the market. Additionally, dental procedures declined due to the fear of virus transmission and critical monitoring of oral health. In the U.S., dental procedures reduced to 25% in March 2020, a fall of 75% from March 2019. This, in turn, reduced the demand for imaging systems during the pandemic. Despite the dip in 2020, the market is said to steadily improve by Q2 of 2022.

Browse through Grand View Research's Medical Devices Industry Research Reports.

Medical X-ray Generators Market - The global medical X-ray generators market size was valued at USD 2.01 billion in 2022 and is expected to expand at a compound annual growth rate (CAGR) of 5.1% from 2023 to 2030.

Digital X-ray Devices Market - The global digital X-ray devices market size was valued at USD 3.6 billion in 2022 and is expected to expand at a compound annual growth rate (CAGR) of 3.0% from 2023 to 2030.

Flat Panel Detector Based X-ray for Cone Beam Computed Tomography Market Segmentation

Grand View Research has segmented the global flat panel detector based x-ray for cone beam computed tomography market based on application, product, end use, and region:

Flat Panel Detector Based X-ray for Cone Beam Computed Tomography Application Outlook (Revenue, USD Million, 2017 - 2030)

• Dental
• ENT
• Orthopedics
• Others

Flat Panel Detector Based X-ray for Cone Beam Computed Tomography Product Outlook (Revenue, USD Million, 2017 - 2030)

• Sitting X-ray
• Standing X-ray
• Lying down X-ray

Flat Panel Detector Based X-ray for Cone Beam Computed Tomography End-use Outlook (Revenue, USD Million, 2017 - 2030)

• Hospitals
• Diagnostic Centres
• Clinics
• Others

Flat Panel Detector Based X-ray for Cone Beam Computed Tomography Regional Outlook (Revenue, USD Million, 2017 - 2030)

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East and Africa

Market Share Insights

December 2019: Vatech America Inc. announced that the i3D Smart dental Cone Beam CT was awarded as the best CBCT for 2020 by the Gordon J. Christensen Clinicians Report.

December 2017: Teledyne DALSA Inc. announced the launch of the GV 4000 vision system. It is a multi-camera system that offers more memory sources and improvement in performance making it more suitable than its predecessors.

Key Companies profiled:

Some prominent players in the global flat panel detector-based x-ray for cone-beam computed tomography market include:

• Vatech
• Danaher
• Ray Co. Ltd.
• PlanmecaOy
• Varex Imaging Corporation
• Ceflas.c.
• Teledyne DALSA Inc.
• MedPhoton
• Prexion
• i-CAT
• DentsplySirona
• Carestream Health
• Owandy Radiology
• Asahiroentgen Ind.Co., Ltd.

Order a free sample PDF of the Flat Panel Detector Based X-ray for Cone Beam Computed Tomography Market Intelligence Study, published by Grand View Research.

U.S. Laboratory Informatics Market User Perspective Analysis Report by 2030

U.S. Laboratory Informatics Industry Overview

The U.S. laboratory informatics market size was valued at USD 1.20 billion in 2021 and is expected to grow at a compound annual growth rate (CAGR) of 3.5% from 2022 to 2030. The growing demand for laboratory automation is expected to boost the adoption of laboratory information systems in the future. Surging demand for scientific data integration solutions among end-use industries including life sciences, Contract Research Organizations (CROs), food & beverage, and chemicals is projected to boost the market growth. The increasing need for clinical workflow management in laboratories to improve operational efficiency is likely to propel the market in the coming years.

Furthermore, the rising adoption of Laboratory Information Management Systems (LIMS) among independent and hospital-based labs to reduce the incidence of diagnostic errors and manage high data volumes is one of the key factors stirring up the adoption of laboratory informatics in the U.S. The COVID-19 pandemic affected the market as it has enforced the government and agencies to develop and introduce the COVID-19 vaccine to control the severity in cases. In addition, high volumes of WHO-recommended COVID-19 tests encouraged the implementation of healthcare laboratory informatics solutions. Likewise, numerous healthcare laboratory informatics market players are quickly incorporating Artificial Intelligence (AI) and data analytics to conduct further research on the different virus strains.

Gather more insights about the market drivers, restraints, and growth of the U.S. Laboratory Informatics market

Significant adoption of LIMS has been seen since the COVID-19 pandemic onset, allowing healthcare professionals to focus on drug and vaccine development by smoothening data collection procedures. Key players in the laboratory information systems are collaborating with public and private sector groups to employ advanced technologies for executing COVID-19-testing capabilities. In addition, laboratory information systems offer benefits, such as improved regulatory compliance, systems process optimization, intellectual property rights protection, paperless information management, and reduced throughput time.

They also offer improved information quality, reduce the labor cost, and provide faster & effective data analytics. Owing to the associated benefits, these systems are being increasingly used by CROs, biobanks, and academic research institutes. Furthermore, the growing adoption of wireless technologies in laboratories to allow remote access to information is estimated to fuel growth prospects. In addition, advancements in laboratory equipment help in replacing manual data evaluation methods, including the construction of calibration curves, and measuring peak areas or height in a shorter time than traditional methods. For instance, the Autosampler robotic system helps in sample preparation, which eliminates errors and saves cost & time on process execution.

Browse through Grand View Research's Healthcare IT Industry Research Reports.

Laboratory Information Management System Market - The global laboratory information management system market size was valued at USD 2.07 billion in 2022 and is expected to expand at a compound annual growth rate (CAGR) of 6.7% from 2023 to 2030.

Electronic Lab Notebook Market - The global Electronic Lab Notebook (ELN) market size was estimated at USD 532.0 million in 2018 and is anticipated to expand at a CAGR of 4.8% over the forecast period.

U.S. Laboratory Informatics Market Segmentation

Grand View Research has segmented the U.S. laboratory informatics market on the basis of product, delivery mode, component, and end use:

U.S. Laboratory Informatics Product Outlook (Revenue, USD Million, 2017 - 2030)

• Laboratory Information Management Systems (LIMS)
• Electronic Lab Notebooks (ELN)
• Scientific Data Management Systems (SDMS)
• Laboratory Execution Systems (LES)
• Electronic Data Capture (EDC) & Clinical Data Management Systems (CDMS)
• Chromatography Data Systems (CDS)
• Enterprise Content Management (ECM)

U.S. Laboratory Informatics Delivery Mode Outlook (Revenue, USD Million, 2017 - 2030)

• On-Premise
• Web-hosted
• Cloud-based

U.S. Laboratory Informatics Component Outlook (Revenue, USD Million, 2017 - 2030)

• Software
• Services

U.S. Laboratory Informatics End-use Outlook (Revenue, USD Million, 2017 - 2030)

• Life Sciences
• CROs
• Chemical Industry
• Petrochemical Refineries and Oil & Gas
• Food & Beverages and Agriculture
• Environmental Testing Labs
• Others Industries

Market Share Insights

September 2021: PerkinElmer completed the acquisition of BioLegend.

August 2021: Abbott Informatics released STARLIMS Laboratory Execution System v1.1. This is built on the latest STARLIMS Quality Manufacturing QM 12.2. Moreover, initiatives, such as a merger, acquisitions, product launches further support overall market growth.

Key Companies profiled:

Some of the prominent companies operating in the global U.S. laboratory informatics market are:

• Thermo Fisher Scientific, Inc.
• Waters
• LabWare
• Core Informatics
• LabVantage Solutions, Inc.
• LabLynx, Inc.
• PerkinElmer Inc.
• Abbott
• Agilent Technologies, Inc.
• IDBS

Order a free sample PDF of the U.S. Laboratory Informatics Market Intelligence Study, published by Grand View Research.

Who are the Key Players in Latin American Nutritional Supplements Market?

Latin America Nutritional Supplements Industry Overview

The Latin American nutritional supplements market size was valued at USD 48.1 billion in 2021 and is expected to expand at a compound annual growth rate (CAGR) of 8.1% from 2022 to 2030. The Latin American population has had a history of a high prevalence of chronic diseases like hypertension, diabetes, and metabolic diseases. As per the WHO, more than 60% of the male and female population in the region is overweight or obese. The region has the highest prevalence of nonalcoholic fatty liver disease of nearly 31%. ALANUR, a Latin American Alliance formed in 2011, for information regarding nutrition in the region, states, that in a period of fewer than 20 years, the sales of nutritional supplements in the Latin American region doubled from 3% in 1999 to 7% in 2017. According to Glanbia Nutritionals, more than 50% of consumers plan to become more active after COVID-19. Immunity boosting supplements accounted for the majority of purchasing the nutritional supplements during the pandemic. More than 80% of Brazilians showed interest in purchasing vitamins, minerals, and other nutritional supplements for boosting their immunity levels. The increase in awareness levels and increase in uptake of products is driving the market growth.

Activity levels have taken a nosedive since the pandemic started, making more people predisposed to chronic ailments. This has made weight loss and maintenance a primary concern for the Latin American people. Glanbia states more than 43% of Latin Americans are becoming conscious of their weight. The high risk of obesity has been a primary reason for the growth of fitness centers and gyms, in turn creating a huge market for sports nutrition, thus aiding the growth of the market. 

Gather more insights about the market drivers, restraints, and growth of the Global Latin America Nutritional Supplements market

Latin American countries have been keenly increasing their uptake of nutritional supplements and more so since the COVID-19 pandemic. As per ALANUR, in Chile, 50% of households are daily consumers of dietary supplements. Out of all the types, vitamins held the largest share owing to their multifarious benefits. Supplementation compliments the diet. It not only completes the daily nutritional requirement but also boosts immunity. More than 90% of the population has a better perception of both mental and physical health post use of nutritional supplements.

Different Latin American countries have different regulatory norms about nutritional supplements. The countries also have different rules for food supplements, all the norms have been in conformation with the Codex Alimentarius guidelines for international food supplement regulation. Many trade blocs exist in the Latin American region like the Southern Common Market (Argentina, Brazil, Paraguay, and Uruguay with Bolivia pending full integration), Pacific Alliance (Chile, Colombia, Mexico, and Peru), and several others. 

Latin America was one of the regions to suffer the worst of the brunt of the COVID-19 pandemic. Due to a high number of already existing comorbidities, the pandemic claimed many lives in the region. A paper published on PubMed, states in June 2020, that Latin America became the largest hotspot for COVID. Preventative health has been gaining momentum ever since COVID-19 which has led to stronger growth of the regional market. A recent study reported, that 3 out of 4 people in Peru have been regularly including immunity-boosting supplements in their diet.

Browse through Grand View Research's Pharmaceuticals Industry Research Reports.

Sports Nutrition Market - The global sports nutrition market size was valued at USD 42.9 billion in 2022 and is expected to expand at a compound annual growth rate (CAGR) of 7.4% from 2023 to 2030.

Bone And Joint Health Supplements Market - The global bone and joint health supplements market size was valued at USD 2.05 billion in 2021 and is expected to expand at a compound annual growth rate (CAGR) of 7.0% from 2022 to 2030.

Latin America Nutritional Supplements Market Segmentation

Grand View Research has segmented the Latin America nutritional supplements market based on product, formulation, consumer, and country:

Latin America Nutritional Supplements Product Outlook (Revenue, USD Million, 2016 - 2030)

• Sports Nutrition
• Dietary Supplements
• Functional Foods

Latin America Nutritional Supplements Consumer Group Outlook (Revenue, USD Million, 2016 - 2030)

• Infants
• Children
• Adults
• Pregnant
• Geriatric

Latin America Nutritional Supplements Formulation Outlook (Revenue, USD Million, 2016 - 2030)

• Tablets
• Capsules
• Powder
• Softgels
• Liquid
• Others

Latin America Nutritional Supplements Sales Channel Outlook (Revenue, USD Million, 2016 - 2030)

• E-commerce
• Brick & Mortar

Key Companies profiled:

Some prominent players in the Latin America nutritional supplements market include:

• Herbalife
• Bayer
• Probiotica
• Nutrilatina
• Pfizer

Order a free sample PDF of the Latin America Nutritional Supplements Market Intelligence Study, published by Grand View Research.

Cancer Supportive Care Drugs Market Raw material Outlook, PESTEL Analysis and Type Estimates

Cancer Supportive Care Drugs Industry Overview

The global cancer supportive care drugs market size was valued at USD 14.03 billion in 2021 and is expected to decline with a compound annual growth rate (CAGR) of -1.57% from 2022 to 2030. The approval and uptake of targeted drugs, which have lesser side effects than traditional chemotherapy drugs, and the launch of biosimilars are expected to impede the market growth. Factors supporting the market include the rising prevalence of cancer, increase in the geriatric population, and high adoption of chemotherapy in low- and middle-income regions. The global COVID-19 pandemic has had a significant impact on cancer care. According to the American Society of Clinical Oncology, there was a substantial decline in visits, cancer screenings, surgeries, and therapy amid the pandemic.

In addition, hospital outpatient evaluation & management (E&M) visits (74%), new patient E&M visits (70%), and existing patient E&M visits (60%) all saw a significant decrease. However, in most regions, around the second quarter of 2021, the overall condition returned to normal. Rising cancer prevalence coupled with the increasing geriatric population is among the most prominent factors driving the market growth. According to Globocan, the number of new cancer cases is anticipated to reach 28.4 million within the next two decades, with a rise of 47% from 2020. Moreover, the geriatric population is more susceptible to cancer; in developing economies, life expectancy is now exceeding 80 years.

Gather more insights about the market drivers, restraints, and growth of the Global Cancer Supportive Care Drugs market

According to the U.S. National Cancer Institute’s SEER Database, around two-thirds of all new cancer cases are diagnosed in people aged 65 years and above, showing that aging can make people more vulnerable to such disease. With the rise in technological advancements, major players are primarily focusing on the development of novel targeted therapies for the treatment of cancer. It has lesser adverse effects than traditional treatments, such as chemotherapy. These factors can impede the market growth over the forecast period. For instance, in April 2020, Gilead Sciences, Inc. received accelerated approval for Trodelvy (sacituzumab govitecan-hziy) from the U.S. FDA.

It is indicated for the treatment of patients with triple-negative breast cancer. It is an antibody-drug conjugate that targets and kills specific infectious cells through its toxic chemical molecule, hence having lesser side effects than chemotherapy and other traditional treatments. Furthermore, biosimilars and generic drugs gaining traction is another factor hampering the market growth. Companies are launching biosimilars of key drugs, impeding the growth of branded drugs. For instance, in June 2020, Pfizer received the approval for its NYVEPRIA, a biosimilar for Amgen’s NEULASTA.

Browse through Grand View Research's Pharmaceuticals Industry Research Reports.

Erythropoietin Drugs Market - The global erythropoietin drugs market size was valued at USD 6.87 billion in 2022 and is expected to expand at a compound annual growth rate (CAGR) of 1.5% from 2023 to 2030.

Radiation Oncology Market - The global radiation oncology market size was valued at USD 8.65 billion in 2022 and is expected to expand at a compound annual growth rate (CAGR) of 12.3% from 2023 to 2030.

Cancer Supportive Care Drugs Market Segmentation

Grand View Research has segmented the global cancer supportive care drugs market based on therapeutic class and region:

Cancer Supportive Care Drugs Therapeutic Class Outlook (Revenue, USD Million, 2017 - 2030)

• G-CSFs (Granulocyte-colony Stimulating Factors)
• ESAs (Erythropoiesis Stimulating Agents)
• Anti-emetics
• Bisphosphonates
• Opioids
• NSAIDs & Others

Cancer Supportive Care Drugs Regional Outlook (Revenue, USD Million, 2017 - 2030)

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa

Market Share Insights

June 2020: Pfizer Inc. received the U.S. FDA approval for NYVEPRIA (pegfilgrastim-apgf), a biosimilar to Neulasta. It reduces the incidence of febrile neutropenia in patients with non-myeloid malignancies undergoing myelosuppressive anticancer medications.

November 2019: Novartis AG received the FDA approval for Ziextenzo, its biosimilar version of pegfilgrastim. The product was commercialized in Europe in 2018.

Key Companies profiled:

Some of the prominent companies operating in the global cancer supportive care drugs market include:

• Amgen, Inc.
• Merck & Co., Inc.
• Johnson & Johnson Services, Inc.
• Heron Therapeutics, Inc.
• Novartis AG
• GlaxoSmithKline plc (GSK)
• F. Hoffmann-La Roche Ltd.
• Helsinn Healthcare SA

Order a free sample PDF of the Cancer Supportive Care Drugs Market Intelligence Study, published by Grand View Research.